EMERGENT BIOSOLUTIONS INC. Goodwill, Acquired During Period
EMERGENT BIOSOLUTIONS INC. (EBS) reported Goodwill, Acquired During Period of $100.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-19.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2021-02-19
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for the quarter ending 2015-12-31 was $2.32M.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for fiscal 2020 was $100.00K.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for fiscal 2018 was $210.60M, a 2599900.00% increase from fiscal 2017.
- EMERGENT BIOSOLUTIONS INC. goodwill, acquired during period for fiscal 2017 was $8.10K.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $100.00K 10-K · filed 2021-02-19 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-02-19 | ||||
| 2018-12-31 | $210.60M 10-K · filed 2020-02-25 | $210.60K 10-K · filed 2019-02-22 | |||
| 2017-12-31 | $8.10K 10-K · filed 2019-02-22 | $8.13M 10-K · filed 2018-02-23 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | ||||
| 2015-12-31 | $2.32M derived: 10-K 12 month − 3 quarters · filed 2016-02-29 | $2.32M derived: sum of 2 quarters · filed 2016-02-29 | $2.32M derived: sum of 3 quarters · filed 2016-02-29 | $2.32M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $0.00 derived: sum of 3 quarters · filed 2015-11-06 | -$65.78M derived: sum of 4 quarters · filed 2015-11-06 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 2 quarters · filed 2015-08-06 | -$65.78M derived: sum of 3 quarters · filed 2015-08-06 | -$38.44M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | -$65.78M derived: sum of 2 quarters · filed 2015-05-08 | -$38.44M derived: sum of 3 quarters · filed 2015-05-08 | -$5.20M derived: sum of 4 quarters · filed 2015-05-08 | |
| 2014-12-31 | -$65.78M derived: 10-K 12 month − 3 quarters · filed 2015-03-09 | -$38.44M derived: sum of 2 quarters · filed 2015-03-09 | -$5.20M derived: sum of 3 quarters · filed 2015-03-09 | $28.03M 10-K · filed 2015-03-09 | |
| 2014-09-30 | $27.35M 10-Q · filed 2014-11-10 | $60.58M derived: sum of 2 quarters · filed 2014-11-10 | $93.81M derived: sum of 3 quarters · filed 2014-11-10 | ||
| 2014-06-30 | $33.23M 10-Q · filed 2014-08-08 | $66.47M derived: sum of 2 quarters · filed 2014-08-08 | |||
| 2014-03-31 | $33.23M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |